• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
swelem, R., Abdelrahman, A., imbaby, S., Ahmed, N. (2024). PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS. ALEXMED ePosters, 6(2), 39-40. doi: 10.21608/alexpo.2024.296944.1865
rania shafik swelem; Ahmed Shehata Abdelrahman; salma alaa eldin imbaby; Nourane Khaled Abdellah Ahmed. "PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS". ALEXMED ePosters, 6, 2, 2024, 39-40. doi: 10.21608/alexpo.2024.296944.1865
swelem, R., Abdelrahman, A., imbaby, S., Ahmed, N. (2024). 'PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS', ALEXMED ePosters, 6(2), pp. 39-40. doi: 10.21608/alexpo.2024.296944.1865
swelem, R., Abdelrahman, A., imbaby, S., Ahmed, N. PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS. ALEXMED ePosters, 2024; 6(2): 39-40. doi: 10.21608/alexpo.2024.296944.1865

PROGNOSTIC VALUE OF CTBP2 AND CASP8AP2 EXPRESSION IN ADULT ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA PATIENTS

Article 1, Volume 6, Issue 2, April 2024, Page 39-40  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.296944.1865
View on SCiNiTO View on SCiNiTO
Authors
rania shafik swelem1; Ahmed Shehata Abdelrahman2; salma alaa eldin imbaby3; Nourane Khaled Abdellah Ahmed email 4
1clinical pathology, faculty of medicine, alexandria university
2Departments of internal medicine, Hematology, Faculty of Medicine, University of Alexandria, Egypt
3Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of medicine, Alexandria university, Egypt.
4Department of Clinical and Chemical Pathology, Alexandria University, Egypt.
Abstract
Acute lymphoblastic leukemia is a clonal proliferationof the lymphocyte precursor cells. Both T-cell and B-cell precursors can give rise to ALL.Molecular markers have made a breakthrough in ALL after proving to be important in disease pathogenesis and as therapeutic targets. The C-terminal binding protein 2 (CTBP2) is a transcriptional repressor that was reported to correlate with tumorigenesis and progression in several cancers. Down-regulation of CTBP2 mediated by some tumor suppressors results in p53-independent apoptosis and reduced tumor cell migration and invasion. Caspase-8 associated protein 2 (CASP8AP2) has been recognized as a key mediator of apoptosis. Previous studies conducted stated that low expression of CTBP2 and CASP8AP2 gene was associated with relapse in childhood B-ALL. Yet, minimal studies have been conducted to evaluate the prognostic role of CTBP2 and CASP8AP2 gene expression in adult B-ALL.
AIM:
The aim of this study was to investigate the expression of CTBP2 and CASP8AP2 genes in newly diagnosed cases of acute B-cell lymphoblastic leukemia in adult patients in relation with other clinicopathological parameters.
Keywords
LEUKEMIA; CTBP2; CASP8AP2
Supplementary Files
download 1865 19 (62).pdf
Statistics
Article View: 82
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.